Jan Mollenhauer

Title: Jan Mollenhauer: Innovator in Biomedical Research

Introduction

Jan Mollenhauer is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of innovative treatments and diagnostic methods. With a total of 2 patents, Mollenhauer's work has the potential to impact the medical community significantly.

Latest Patents

Mollenhauer's latest patents include groundbreaking inventions. The first patent involves the use of DMBT1 for capturing sulphate and phosphate group exposing agents. This invention discloses the use of DMBT1, or the nucleic acid encoding it, for manufacturing a medicament aimed at treating patients suffering from diseases caused by agents with accessible sulphate and/or phosphate groups. Additionally, it outlines methods for diagnosing, prophylaxis, or treatment of such diseases. The second patent pertains to a protein containing a scavenger receptor cysteine-rich domain. This invention relates to a protein with an SRCR domain, a nucleic acid encoding the protein, and methods for its production. It also discusses the use of the nucleic acid, the protein, and antibodies directed against the protein.

Career Highlights

Throughout his career, Jan Mollenhauer has worked with prestigious institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum). His work at these institutions has allowed him to focus on innovative research that addresses critical health issues.

Collaborations

Mollenhauer has collaborated with esteemed colleagues such as Annemarie Poustka and Caroline End. These collaborations have further enriched his research and contributed to the advancement of his inventions.

Conclusion

Jan Mollenhauer is a distinguished inventor whose work in biomedical research has led to significant advancements in treatment and diagnostics. His contributions continue to shape the future of medical science.